Nuveen Asset Management, LLC Esperion Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 2,099,010 shares of ESPR stock, worth $5.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,099,010

Previous 2,272,628 7.64%

Holding current value

$5.06 Million

Previous $5.05 Million 31.36%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.61 - $2.73 $279,524 - $473,977	-173,618 Reduced 7.64%	2,099,010 $3.46 Million
Q2 2024 Aug 09, 2024	BUY	$1.84 - $3.24 $4.18 Million - $7.36 Million	2,272,628 New	2,272,628 $5.05 Million
Q1 2023 May 15, 2023	SELL	$1.46 - $7.3 $330,579 - $1.65 Million	-226,424 Reduced 22.22%	792,772 $1.26 Million
Q4 2022 Feb 14, 2023	BUY	$5.09 - $8.5 $3.65 Million - $6.1 Million	717,837 Added 238.2%	1,019,196 $6.35 Million
Q3 2022 Nov 14, 2022	BUY	$5.45 - $8.13 $579,836 - $864,966	106,392 Added 54.57%	301,359 $2.02 Million
Q2 2022 Aug 15, 2022	SELL	$4.77 - $6.67 $696,095 - $973,366	-145,932 Reduced 42.81%	194,967 $1.24 Million
Q1 2022 May 16, 2022	BUY	$3.34 - $5.56 $874,318 - $1.46 Million	261,772 Added 330.83%	340,899 $1.89 Million
Q4 2021 Feb 14, 2022	SELL	$4.81 - $11.92 $91,327 - $226,325	-18,987 Reduced 19.35%	79,127 $395,000
Q3 2021 Nov 12, 2021	SELL	$11.34 - $21.37 $769,804 - $1.45 Million	-67,884 Reduced 40.89%	98,114 $1.23 Million
Q2 2021 Aug 16, 2021	SELL	$19.4 - $28.71 $933,838 - $1.38 Million	-48,136 Reduced 22.48%	165,998 $3.51 Million
Q1 2021 May 17, 2021	BUY	$25.12 - $36.89 $2.41 Million - $3.54 Million	95,919 Added 81.14%	214,134 $6.01 Million
Q4 2020 Feb 16, 2021	SELL	$24.2 - $35.76 $197,084 - $291,229	-8,144 Reduced 6.45%	118,215 $3.07 Million
Q3 2020 Nov 16, 2020	SELL	$31.18 - $52.71 $1.21 Million - $2.04 Million	-38,767 Reduced 23.48%	126,359 $4.7 Million
Q2 2020 Aug 14, 2020	SELL	$30.04 - $51.31 $577,398 - $986,229	-19,221 Reduced 10.43%	165,126 $8.47 Million
Q1 2020 May 14, 2020	BUY	$27.44 - $73.84 $558,980 - $1.5 Million	20,371 Added 12.42%	184,347 $5.81 Million
Q4 2019 Feb 14, 2020	SELL	$35.4 - $59.82 $4.45 Million - $7.52 Million	-125,700 Reduced 43.39%	163,976 $9.78 Million
Q3 2019 Nov 14, 2019	SELL	$34.47 - $47.53 $3.28 Million - $4.52 Million	-95,068 Reduced 24.71%	289,676 $10.6 Million
Q2 2019 Aug 15, 2019	BUY	$40.1 - $52.33 $15.4 Million - $20.1 Million	384,744 New	384,744 $17.9 Million

Others Institutions Holding ESPR

# of Institutions

208

Shares Held

128M

Call Options Held

1.67M

Put Options Held

930K

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $160M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Esperion Therapeutics, Inc. Transaction History